1. Home
  2. UCAR vs AYTU Comparison

UCAR vs AYTU Comparison

Compare UCAR & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UCAR
  • AYTU
  • Stock Information
  • Founded
  • UCAR 2013
  • AYTU N/A
  • Country
  • UCAR China
  • AYTU United States
  • Employees
  • UCAR N/A
  • AYTU N/A
  • Industry
  • UCAR Retail-Auto Dealers and Gas Stations
  • AYTU Biotechnology: Pharmaceutical Preparations
  • Sector
  • UCAR Consumer Discretionary
  • AYTU Health Care
  • Exchange
  • UCAR Nasdaq
  • AYTU Nasdaq
  • Market Cap
  • UCAR 8.8M
  • AYTU 9.6M
  • IPO Year
  • UCAR 2023
  • AYTU N/A
  • Fundamental
  • Price
  • UCAR $1.99
  • AYTU $2.48
  • Analyst Decision
  • UCAR
  • AYTU Strong Buy
  • Analyst Count
  • UCAR 0
  • AYTU 2
  • Target Price
  • UCAR N/A
  • AYTU $10.00
  • AVG Volume (30 Days)
  • UCAR 95.0K
  • AYTU 156.0K
  • Earning Date
  • UCAR 08-12-2025
  • AYTU 09-25-2025
  • Dividend Yield
  • UCAR N/A
  • AYTU N/A
  • EPS Growth
  • UCAR N/A
  • AYTU N/A
  • EPS
  • UCAR N/A
  • AYTU N/A
  • Revenue
  • UCAR $6,067,871.00
  • AYTU $81,659,000.00
  • Revenue This Year
  • UCAR N/A
  • AYTU N/A
  • Revenue Next Year
  • UCAR N/A
  • AYTU $1.05
  • P/E Ratio
  • UCAR N/A
  • AYTU N/A
  • Revenue Growth
  • UCAR 124.09
  • AYTU 0.41
  • 52 Week Low
  • UCAR $1.75
  • AYTU $0.95
  • 52 Week High
  • UCAR $9.43
  • AYTU $2.85
  • Technical
  • Relative Strength Index (RSI)
  • UCAR 27.12
  • AYTU 55.21
  • Support Level
  • UCAR $1.84
  • AYTU $2.32
  • Resistance Level
  • UCAR $2.60
  • AYTU $2.82
  • Average True Range (ATR)
  • UCAR 0.42
  • AYTU 0.16
  • MACD
  • UCAR -0.17
  • AYTU -0.02
  • Stochastic Oscillator
  • UCAR 8.74
  • AYTU 34.62

About UCAR U Power Limited

U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

Share on Social Networks: